Sean K Sethi1, David T Utriainen1, Ana M Daugherty2, Wei Feng3, J Joseph Hewett4, Naftali Raz2, E Mark Haacke1,3. 1. MRI Institute of Biomedical Research, Detroit, Michigan. 2. Institute of Gerontology and Department of Psychology, Wayne State University, Detroit, Michigan. 3. Department of Radiology, Wayne State University, Detroit, Michigan. 4. Synergy Health, Newport Beach, California.
Abstract
BACKGROUND: To determine if extracranial venous structural and flow abnormalities exist in patients with multiple sclerosis (MS). METHODS: Magnetic resonance imaging was used to assess the anatomy and function of major veins in the neck in 138 MS patients and 67 healthy controls (HC). Time-of-flight MR angiography (MRA) was used to assess stenosis while 2-dimensional phase-contrast flow quantification was used to assess flow at the C2/C3 and C5/C6 levels. Venous flow was normalized to the total arterial flow. The MS patients were divided into stenotic (ST) and nonstenotic (NST) groups based on MRA assessment, and each group was compared to the HC group in anatomy and flow. RESULTS: The MS group showed lower normalized internal jugular vein (IJV) blood flow (tIJV/tA) than the HC group (P < .001). In the MS group, 72 (52%) were classified as ST while 66 (48%) were NST. In the HC group, 11 (23%) were ST while 37 (77%) were NST. The ST-MS group had lower IJV flow than both HC and NST-MS groups. CONCLUSION: After categorizing the MS population into two groups based upon anatomical stenosis, as determined from an absolute quantification of IJV cross section, clear differences in IJV flow between the ST-MS and HC samples became evident. Despite the unknown etiology of MS, abnormal venous flow was noted in a distinct group of MS patients compared to HC.
BACKGROUND: To determine if extracranial venous structural and flow abnormalities exist in patients with multiple sclerosis (MS). METHODS: Magnetic resonance imaging was used to assess the anatomy and function of major veins in the neck in 138 MS patients and 67 healthy controls (HC). Time-of-flight MR angiography (MRA) was used to assess stenosis while 2-dimensional phase-contrast flow quantification was used to assess flow at the C2/C3 and C5/C6 levels. Venous flow was normalized to the total arterial flow. The MS patients were divided into stenotic (ST) and nonstenotic (NST) groups based on MRA assessment, and each group was compared to the HC group in anatomy and flow. RESULTS: The MS group showed lower normalized internal jugular vein (IJV) blood flow (tIJV/tA) than the HC group (P < .001). In the MS group, 72 (52%) were classified as ST while 66 (48%) were NST. In the HC group, 11 (23%) were ST while 37 (77%) were NST. The ST-MS group had lower IJV flow than both HC and NST-MS groups. CONCLUSION: After categorizing the MS population into two groups based upon anatomical stenosis, as determined from an absolute quantification of IJV cross section, clear differences in IJV flow between the ST-MS and HC samples became evident. Despite the unknown etiology of MS, abnormal venous flow was noted in a distinct group of MS patients compared to HC.
Authors: Peter Sundström; Anders Wåhlin; Khalid Ambarki; Richard Birgander; Anders Eklund; Jan Malm Journal: Ann Neurol Date: 2010-08 Impact factor: 10.422
Authors: E Menegatti; V Genova; M Tessari; A M Malagoni; I Bartolomei; M Zuolo; R Galeotti; F Salvi; P Zamboni Journal: Int Angiol Date: 2010-04 Impact factor: 2.789
Authors: D Hojnacki; P Zamboni; A Lopez-Soriano; R Galleotti; E Menegatti; B Weinstock-Guttman; C Schirda; C Magnano; A M Malagoni; C Kennedy; I Bartolomei; F Salvi; R Zivadinov Journal: Int Angiol Date: 2010-04 Impact factor: 2.789
Authors: Robert Zivadinov; Alexandra Lopez-Soriano; Bianca Weinstock-Guttman; Claudiu V Schirda; Christopher R Magnano; Kresimir Dolic; Cheryl L Kennedy; Christina L Brooks; Justine A Reuther; Kristin Hunt; Michelle Andrews; Michael G Dwyer; David W Hojnacki Journal: Radiology Date: 2010-12-21 Impact factor: 11.105
Authors: Mike P Wattjes; Bob W van Oosten; Wolter L de Graaf; Alexandra Seewann; Joseph C J Bot; René van den Berg; Bernard M J Uitdehaag; Chris H Polman; Frederik Barkhof Journal: J Neurol Neurosurg Psychiatry Date: 2010-10-27 Impact factor: 10.154
Authors: Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky Journal: Ann Neurol Date: 2011-02 Impact factor: 10.422
Authors: P Zamboni; R Galeotti; E Menegatti; A M Malagoni; G Tacconi; S Dall'Ara; I Bartolomei; F Salvi Journal: J Neurol Neurosurg Psychiatry Date: 2008-12-05 Impact factor: 10.154
Authors: Déborah Tartière; Philippe Seguin; Charlotte Juhel; Bruno Laviolle; Yannick Mallédant Journal: Crit Care Date: 2009-12-09 Impact factor: 9.097
Authors: Sonu Bhaskar; Andrew Bivard; Mark Parsons; Michael Nilsson; John R Attia; Peter Stanwell; Christopher Levi Journal: J Cereb Blood Flow Metab Date: 2016-07-20 Impact factor: 6.200
Authors: S K Sethi; A M Daugherty; G Gadda; D T Utriainen; J Jiang; N Raz; E M Haacke Journal: AJNR Am J Neuroradiol Date: 2017-05-25 Impact factor: 3.825
Authors: L Pelizzari; D Jakimovski; M M Laganà; N Bergsland; J Hagemeier; G Baselli; B Weinstock-Guttman; R Zivadinov Journal: AJNR Am J Neuroradiol Date: 2018-07-26 Impact factor: 3.825
Authors: Emil E Pacurar; Sean K Sethi; Charbel Habib; Marius O Laze; Rachel Martis-Laze; E Mark Haacke Journal: Neuroimage Date: 2015-05-08 Impact factor: 6.556